SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genpharmasec informs about financial results

14 Nov 2022 Evaluate
Genpharmasec has informed that in continuation of the outcome of financial results submitted by the company on 11th November, 2022 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting Conclusion time was inadvertently not mentioned. The company submitted a revised outcome of Board Meeting for approval of Financial results having the required information the Conclusion Time as specified to be given under SEBI Circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015, and there is no change in any financial figures. 

The above information is a part of company’s filings submitted to BSE.

Genpharmasec Share Price

1.11 -0.01 (-0.89%)
23-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 275.90
Amrapali Industries 38.19
Adani Enterprises 2963.70
Rashi Peripheral 735.75
PDS 354.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: